about
Practical aspects of NGS-based pathways analysis for personalized cancer science and medicinePhase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer.Opportunities and challenges in combination gene cancer therapy.A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.Oncogenic regulation of tumor metabolic reprogramming.Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation.Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy.Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets.Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas.Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/β-catenin pathway.Molecular Mechanisms Underlying the Inhibitory Effects of Qingzaojiufei Decoction on Tumor Growth in Lewis Lung Carcinoma.The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors.The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer
P2860
Q26748603-41267A88-A005-4108-88E6-48FB531EB719Q33434141-4F4A2EF6-795E-413B-803A-E531E2C28395Q33861035-392DF483-006C-4ED7-BF23-D9823A48A8FCQ36111892-767348B0-7B07-4D9B-AE5C-785C0BE50404Q36328010-CF6CE3BA-ECF8-4921-98FA-E7048DCEB8B3Q37118663-7152D765-E460-4D0C-ABC7-1C3D434B3CA3Q38838357-4607B7D1-413A-4A55-A68C-19E96D1FABA2Q39229171-BE3B1EA4-7830-465E-98A3-9E659DA11B87Q42321596-AAAEA9A9-231B-4F5B-A244-9AF80A163D6AQ44872362-4D8AA1B7-B303-41FC-9CFC-67564EEF9E50Q47169597-CF5DEC29-71FB-4A3D-AC10-433E6B438192Q47243883-2323DF20-FD09-48AB-B961-39C1CBE75F7FQ48224260-D9CE6F08-4CFA-480F-A06A-9281E549F5A4Q49787268-C65CAF30-8538-496D-BC48-7976888196AFQ50943660-8FF6001C-AF60-43C0-9364-E05FA42C2992Q52370690-71EAB064-3985-4882-947E-E8DCFDD6A29EQ52661829-9EDEDD99-B835-43EA-A875-22E2FC3F71C3Q55274011-1D0E3CE0-2D21-4EE1-B3EA-5E0DCB187D03Q58572197-279CFDAC-71DE-4366-927F-DC001E9C2D24
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Therapeutic targeting of tumor suppressor genes
@en
type
label
Therapeutic targeting of tumor suppressor genes
@en
prefLabel
Therapeutic targeting of tumor suppressor genes
@en
P2860
P356
P1433
P1476
Therapeutic targeting of tumor suppressor genes
@en
P2093
Luc G T Morris
Timothy A Chan
P2860
P304
P356
10.1002/CNCR.29140
P407
P577
2014-12-29T00:00:00Z